Pharma Focus Asia
Advertise | About Us | Contact Us
QPS - Full-Service Contract Research Organization

Techno Trends

TechnoTrends provide comprehensive coverage of the innovations and inventions in pharma products and pharma technologies across the world. The up-to-date listing of latest pharmaceutical product news and technology trends in the global pharma industry, keeps you abreast with all the latest pharmaceutical innovations happening world over.

Novel Agent Reactivates an Immune Call by LIF Blockade

Novel agent reactivates is a new therapy with dual mechanism of action to eliminate malignant stem cells and activate the immune system.

A 3D-Printed Clinical Device Intended to Detect Biomarkers of Preterm Birth

The 3D-Printed device is a microchip electrophoresis device that can sensitively detect three serum biomarkers of Preterm birth (PTB).

Cyclica Launches First-of-its-kind Ligand DesignTM

Cyclica, a biotechnology company announced its novel, first-in-class drug design technology, Ligand DesignTM at the Collision Conference in Toronto.

York University Scientists Discover a Novel Gene to Prevent the Spread of Muscle Cancer

York University scientists have discovered a unique set of genes in muscle cellular gene expression and differentiation that could lead to new therapeutic targets to prevent the spread of muscle cancer.

UW–Madison School of Pharmacy Designs New Compounds to Fight Deadly Mosquito-Transmitted Viruses

UW-Madison school of Pharmacy designed a breakthrough in creating new small molecules that penetrate into the brain where the virus resides and interfere with viral replication to stop Equine Encephalitis Viruses (EEV).

Nanopore-based DNA Sequencing Technology to Diagnose Genetic Disorder Huntington's Disease

Nanopore-based DNA sequencing technology has been developed to diagnose the genetic disorder Huntington’s Diseases, for the first time in the world.

Wistar Scientists Develop Innovative Synthetic DNA-based Cancer Immunotherapy Approach

Wistar scientists have developed a novel innovative synthetic DNA approach for patient-specific production of cancer-targeting molecules called bispecific T cell engagers (BiTEs).

PhaseBio to Announce PB2452, a Novel Reversal Agent for Antiplatelet Drug Ticagrelor

PhaseBio Pharmaceuticals is planning to announce PB2452, a novel reversal agent for the Antiplatelet drug Ticagrelor. PB2452 is a novel, recombinant, human monoclonal antibody antigen-binding fragment, or Fab fragment, designed to reverse the Antiplatelet activity of ticagrelor in major bleeding and urgent surgery situations.

NUS Chemists Develop Novel Ratiometric Fluorescent Probe

NUS chemists have developed a novel ratiometric fluorescent probe, known as RDC1, for studying cellular activity of the clinically important anticancer drug cisplatin for next generation drug development.

Nottingham University Launches First-of-its-kind Equipment for Chemical Imaging of Materials, Cells & Tissues

The University of Nottingham launched unique, first-of-its-kind equipment, 3DOrbiSIMS, which allows label-free chemical imaging of materials, cells and tissues, with the potential to transform research in these areas.

3DOrbiSIMS will have applications in a multi-disciplinary range of research areas. These areas include biomedical implants, drug delivery systems, developing strategies to tackle antimicrobial re